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The probiotic properties of the riboflavin producing lactic acid bacterium, Lactobacillus 
fermentum MTCC 8711 were evaluated. The strain was resistant to the acidic 
environment with the pH of 3.5 and more than 100% survivability of the cells was 
observed after 4 h. Similarly, 85% survivability was observed in the presence of 0.3% 
(w/v) bile salts. The strain exhibited β- galactosidase activity by blue colored colony 
formation in the MRS agar plates with X-gal and IPTG. Further, it was found to be a 
medium acidifier with a pH value of 0.96 after 5 h of growth. The strain was also able 
to reduce the cholesterol up to 50% in the presence of cholesterol and bile salts. Since 
the strain possesses the basic properties of the probiotics and produces riboflavin, it 
could be considered as a better starter culture in the fermented food industry.   
 
1. Introduction 
'Probiotics’ are live microorganisms, which 
impart health benefits to the host beyond inherent 
general nutrition (Guarner and Schaafsma, 1998). 
The probiotic bacteria include lactic acid bacteria 
(LAB), bifidobacteria, certain yeasts and bacilli. 
LAB are a major class of bacteria with probiotic 
properties, and the strains of Lactobacillus acidophilus, 
Lb. johnsonii, Lb. casei, Lb. rhamnosus, Lb. gasseri, and 
Lb. reuteri were reported for the probiotic 
preparations (Heller, 2001). They have been studied 
widely owing to their multifaceted application in 
various fermentations in the form of starter 
cultures.  
Though the mechanism by which the probiotic 
bacteria act is largely not known, few of them could 
involve in the modification of the gut pH, 
competing for pathogen binding and receptor sites 
as well as for available nutrients and growth factors, 
stimulating immunomodulatory cells, and 
producing lactase (Parvez et al., 2006). The health 
benefits attributed by the probiotics include, 
boosting the immunity, reducing the duration of 
certain diarrheal diseases, treatment of gastro 
intestinal disorders including Helicobacter pylori 
infections, and inflammatory bowel diseases, such 
as Crohn’s disease and irritable bowel syndrome, 
and reducing the development of atopic diseases in 
children (Senok et al., 2005).  
The large consumption of probiotic by humans 
is in the form of dairy products containing LAB. 
LAB ferments various substrates like lactose, 
biogenic amines and allergenic compounds into 
short-chain fatty acids and other organic acids and 
gases along with other gut microflora (Gibson and 
Fuller, 2000). Probiotics are provided in products in 
one of following three basic ways: (i) as a culture 
concentrate added to a food (usually a dairy 
product) at medium levels, with little or no 
opportunity for culture growth; (ii) inoculated into 
a milk-based food (or dietary supplement) and 
allowed to grow to achieve high levels in a 
fermented food; (iii) as concentrated and dried cells 
packaged as dietary supplements such as powders, 
capsules, or tablets.  
Fermented dairy products such as yoghurt, 
kefir, butter milk and cultured milk serve as a good 
source of probiotics. Among them, yoghurt is a 
staple food in Asian countries and has much been 
employed as a good source of probiotic. It is 
savored owing to its refreshing acidic and buttery 
taste, nutritive content and therapeutic properties 
which are preserved by the fermentation. Few 
health benefits harnessed by consuming yoghurt 
includes anti allergenic effect to milk protein, 
enhancing the bioavailability of other nutrients, 
breakdown of lactose to monosaccharide for 
improved digestibility boon for lactose intolerant 
people, increasing the calcium bioavailability, 
exerting antibiotic effect against gastrointestinal 
infections, stimulating the immunity, anticholesterol 
activity and anticancer effect (Otto,1988; Shahani 
and Chandan, 1979). Yoghurt exhibits antagonistic 
effect against a number of pathogenic and spoilage 
organisms both in vivo and in vitro (Hattingh and 
Viljoen, 2001). All these health benefits of yogurt 
are mainly attributed to the presence of LAB and to 
high calcium content (Banon, 1999). Few of the 
criteria based on which the probiotics are selected 
include, acid and bile stability, production of β-
galactosidase enzyme, cholesterol assimilation, and 
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adherence to human intestinal cells (Gibson and 
Fuller, 2000). In this study, the probiotic properties 
of the riboflavin producing strain, Lb. fermentum 
MTCC 8711 was evaluated.   
 
2. Materials and Methods 
Microorganism 
A riboflavin producing lactic acid bacterium 
was isolated from the yoghurt sample of the Vellore 
district, Tamil Nadu, India. By biochemical 
characterization and 16S rDNA sequencing, it was 
identified as Lactobacillus fermentum and the strain has 
been deposited in Microbial Type Culture 
Collection and Gene Bank, Chandigarh, India with 
the accession number of MTCC 8711. Previously, 
we have reported the characteristic features and the 
production of riboflavin by this strain (Jayashree et 
al., 2010). In this study, the probiotic properties of 
this strain were examined. 
Acid tolerance  
Acid tolerance of the strain was evaluated by 
viable count method as described by Gililand et al. 
(1984). One ml of the culture  grown in the MRS 
broth for three generations having an A600 value of 
0.28 at was inoculated in 9 ml of sterile MRS broth 
whose pH was adjusted to 3.5 with 5 N HCl. The 
culture was incubated at 37°C for 4 h under static 
conditions. One ml of samples collected at 0 h and 
after 4 h was serially diluted with sterile saline, in 
order to neutralize the acidity, and plated onto MRS 
agar plates. The plates were incubated at 37°C for 
24 h and the CFU were calculated using colony 
counter (Serve well instruments, Banglore, india). 
The survivability of the culture after the exposure 
to low pH for 4 h was considered as the criteria for 
acid tolerance. The percentage survivability was 
calculated as follows: 
% survivability = (log CFU 4 h / log CFU 0 h) 
×100  
Bile tolerance 
The bile tolerance of the strain was evaluated 
by the method of Gililand et al. (2004). This was 
done by cultivating the cells on MRS broth with 
0.3% (w/v) bile salts mixture (HiMedia, Mumbai, 
India) at 37°C for 24 h. The viability was checked 
by spreading of 100 μl of overnight grown cultures 
of appropriate dilutions onto MRS agar. Percentage 
survivability of the strains to 0.3% bile salts was 
calculated using the formula given below: 
% survivability = (log CFU 24 h / log CFU 0 h) 
×100  
β-galactosidase activity  
The β-galactosidase activity of the strain was 
performed by the method described by Karasova et 
al. (2002). The organism was plated onto MRS agar 
containing 0.01% X-gal (HiMedia, Mumbai, India) 
and 0.1 mM IPTG (HiMedia, Mumbai, India) as 
inducer and incubated for 24 h at 37ºC. The β-
galactosidase production of the strain was indicated 
by formation of the blue colored colonies. 
Acidifying activity 
Acidification was measured by the change in 
pH (pH) according to the method described by 
Ayad et al. (2004). Five ml of MRS broth was 
inoculated with 1% of overnight grown culture and 
incubated at 37°C. The pH was measured every one 
hour for 24 h using a pH-meter (Thermon Electron 
Corporation, Beverly, USA). The acidification 
values were expressed as pH, which is calculated 
as follows:  
pH= pHt - pH0, where pHt is the pH of the 
culture at time t and pH0 is the pH at 0 h. The 
criteria for the classification of the strain as fast, 
medium or slow acidifier was based on the pH 
value of 0.4 achieved after 3, 3-5 and > 5 h, 
respectively. 
Cholesterol assimilation assay 
Cholesterol assimilation property was 
determined by the method described by Searcy and 
Bergquist (1960). Lb. fermentum MTCC 8711 was 
grown in MRS broth supplemented with 0.3% bile 
salt mixture. 10 mg of cholesterol dissolved in 500 
µl of ethanol was added to 100 ml of MRS broth 
with bile salt. The cultures were grown for 24 h at 
37°C and the cells were removed by centrifugation 
at 8000 rpm for 10 min at 4°C. The spent broth 
was collected and the cholesterol level was 
estimated. The uninoculated broth was considered 
as control. To the 1 ml of spent broth, 3 ml of 95% 
ethanol followed by 2 ml of 50% potassium 
hydroxide were added. The contents were mixed 
well after the addition of each component. The 
tubes were heated for 10 min at 60°C in a water 
bath. After cooling, 5 ml of hexane was dispensed 
to all tubes and vortexed for 5 min at 20-second 
interval. Then 3 ml of water was added and mixed 
thoroughly. Tubes were allowed to stand for 15 
min at 30°C to permit phase separation. 2.5 ml of 
hexane layer was transferred to a fresh test tube and 
allowed to dry completely. 1.5 ml of ferric chloride 
reagent was added to each test tube and allowed to 
stand for 10 min. One ml of concentrated sulphuric 
acid was added along the sides of the tube. The 
mixture was vortexed and allowed to stand for 45 
min at 30°C. The absorbance was measured at 540 
nm in spectrophotometer (Model UV-1700, 
Shimadzu, Tokyo, Japan). The concentration of 
cholesterol was determined using cholesterol 
standard graph. The percentage assimilation was 
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Antibiotic susceptibility test 
Disk diffusion method described by Bauer et al. 
(1966) was followed for antibiotic susceptibility test. 
The bacterial culture of Lb. fermentum MTCC 8711 
was inoculated into the MRS broth and incubated 
at 37 ºC for 12 h. Plates were made with Muller 
Hinton agar (Himedia, Mumbai, India) and allowed 
to solidify. A lawn culture was made on the plates 
using sterile swabs. The antibiotic discs of 
kanamycin, penicillin, vancomycin, ampicillin, 
streptomycin, bacitracin, trimethoprim, rifampicin 
(HiMedia, Mumbai, India) were placed in the plates. 
Agar plates with antibiotic disks were then 
incubated for 24 h. The diameters of the inhibition 
zones were measured using a ruler under a colony 
counter apparatus and the susceptibility pattern 
were recorded as per the manufacturer’s 
instructions.  
3. Results and Discussion 
Acid tolerance 
The probiotic LAB that are acquired through 
food consumption should sustain in the acidic 
conditions of the gastro intestinal tract in order to 
deliver its beneficial effects. The time required from 
entrance up to release from the stomach has been 
estimated to be approximately 90 min, wherein the 
further digestive processes requires longer 
residence time (Berrada, 1991). The acid tolerant 
capacity of the LAB differs from strain to strain 
(Ross et al., 2005). In this study, more than 100% 
of survivability of cells was observed after 4 h of 
exposure to the acid environment of pH 3.5. The 
log CFU value was increased from 5.85 to 6.90 
after 4 h of incubation indicating that the strain is 
able to grow at pH 3.5.  Similarly, Chou and 
Weimer (1999) had investigated and reported the 
acid tolerance of Lactobacillus acidophilus at pH 3.5.  
Bile tolerance 
To exploit a lactic acid bacterial strain as a 
probiotic, it is necessary to evaluate its ability to 
resist the effect of bile salts (Lee and Salminen, 
1995). The exact mechanism for the bile salt 
resistance is not well understood but thought to be 
through the bile salt hydrolase (BSH) activity. More 
than 85% of the cells of Lb. fermentum MTCC 8711 
were able to survive in the presence of the bile salt 
mixture concentration of 0.3% after 24 h of growth, 
exhibiting their bile tolerance capacity. The log 
CFU value was decreased from 7.80 to 6.84 with 
87.69% of the survivability. 
β-galactosidase activity 
β -galactosidase is an enzyme that catalyzes the 
hydrolysis of the β -galactosides into 
monosaccharide sugars. The LAB possessing these 
enzymes can break down the galactose units of the 
milk and could make it simpler for the 
consumption of lactose intolerant people. Lactose 
intolerance is a wide spread disorder found in 
people who lack the enzyme lactase characterized 
by flatulence and bloating. Such people can tolerate 
lactose from yoghurt better than from milk 
(Sanders, 2000). Dairy products obtained by the 
probiotic organisms with β-galactosidase activity 
could be well suited for the lactose intolerant 
people. The strain Lb. fermentum MTCC 8711 
possessed the β-galactosidase activity, which was 
determined by blue colored colony formation in 
MRS agar with 0.1% X-gal and 0.1 mM IPTG (Fig. 
1).  




















Fig. 1. The β-galactosidase activity of Lb. fermentum MTCC 8711 in MRS agar with 0.01% X-gal and 0.1 mM IPTG exhibiting the 
blue coloured colony formation.
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Acidifying property 
Acidifying property of a LAB strain is very 
important in the fermented food industry for the 
coagulation of adventitious micro flora especially in 
the cheese preparation and is also used as adjunct 
cultures for their autolytic and amino peptidase 
activity (Ayad et al., 2004). The strain Lb. fermentum 
was found to be medium acidifier with pH value 
of 0.96 after 5 h. The acidifying property of this 
















Fig. 2. Acidifying property of Lactobacillus fermentum MTCC 8711. 
 
Cholesterol assimilation property 
Elevated level of certain blood lipids like 
cholesterol is a greater risk for cardiovascular 
disease. Among the probiotic effects of the lactic 
acid bacteria (LAB), the assimilation of cholesterol 
is very important for reducing the absorption of 
dietary cholesterol from the digestive system into 
the blood (Hepner, 1979). Many studies have 
shown that the cholesterol removal would be 
related to the ability of the cultures to deconjugate 
bile salts (Gilliland and Walker, 1989). The 
application of Lb. acidophillus as probiotic has been 
shown to decrease the serum cholesterol levels in 
human and animals (Lee et al., 1992). Lim et al. 
(2004) have reported 57.0%, 64.4% and 58.6% 
hypo cholesterolemic effects by Streptococcus HJS-1, 
Lactobacillus HJL-37 and Bifidobacterium HJB-4 
respectively. In the present study, Lb. fermentum 
MTCC 8711 showed up to 50% of reduction in 
cholesterol level in the MRS broth supplemented 
with cholesterol and 0.3% bile salts mixture. The 
probiotic properties of the strain Lb. fermentum 
MTCC 8711 is summarized in Table 1. 
 
Table 1. The probiotic properties of Lb. fermentum MTCC 8711. 
 
Probiotic properties Results 
Riboflavin production Positive 
β-galactosidase activity Positive 
Acid tolerance >100% 
Bile tolerance >85% 
Acidifying property Medium acidifier (pH = 0.96 after 5 h) 
Cholesterol assimilation Reduces the cholesterol up to 50% 
 
Antibiotic susceptibility  
Probiotic strains should possess resistance to 
commonly used antibiotics, in addition to their 
metabolic activities benefiting the well being of the 
host. The strain was resistant to chloramphenicol, 
rifampicin, trimethoprim and vancomycin.  Since 
the strain is resistant to these antibiotics, it could be 
an efficient probiotic organism as it can persist 
during antimicrobial chemotherapy. However, these 
resistance patterns should be intrinsic and non 
transmissible. The transmission of antibiotic 
resistance to unrelated pathogenic bacteria in the 
gut is a major health concern, with obvious 
ramifications for the selection and safety of 
probiotic strains (Curragh and Collins, 1992). 
Studies on localization of these genes in the 
genome, i.e., whether these genes are coded in the 
chromosome or the transferrable plasmids, are 
under progress. The strain was sensitive to 
ampicillin, tetracycline, erythromycin and 
Kanamycin. Similarly, Zhou et al. (2005) have 
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reported that the probiotic organisms belong to 
Lactobacillus and Bifidobacterium were susceptible to 
β-lactam antibiotics such as penicillin G and 
ampicillin.  
Conclusion 
Probiotics impart health benefits at a lower 
cost and are utilized in the developing countries like 
India. The strain Lb. fermentum MTCC 8711 
produces riboflavin, which is an essential vitamin. 
In this study, we have shown that the organism 
possess probiotic properties such as acid tolerance, 
bile tolerance, β-galactosidase activity, acidifying 
property and cholesterol assimilation efficiency. 
Therefore, this strain could be considered as better 
starter culture as it has the riboflavin producing 
ability and probiotic properties.   
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